← SynDRA
PIDOTIMOD
SynDRA canonical compound SYN0025399 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | interferon receptor agonist | interleukin receptor agonist |
|---|
| Indication | immune adjuvant |
|---|
| Disease area | infectious disease |
|---|
Mechanisms of action (all sources)
- interferon receptor agonist
- interleukin receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- HRH2
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- IDH1
- KCNH2
- MAOA
- MAPK1
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HRH3
- HRH1
- ADORA2A
- HDAC6
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- APEX1
Drug classes
- Adjuvants, Immunologic
- Immunologic Factors
ATC classes
Cross-references
Synonyms
- adimod
- pigitil
- polimod
- Pilimod
- NSC-759841
- Pgt-1A
- 3-Pyroglutamylthiazolidine-4-carboxylic acid
- 3-(5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
- NSC678119
- 3-((5-Oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid
- 3-L-pyroglutamyl-L-thiazolidine-4-carboxylic acid
- 4-Thiazolidinecarboxylic acid, 3-((5-oxo-2-pyrrolidinyl)carbonyl)-
- C9H12N2O4S
- 3-(5-oxoprolyl)-1,3-thiazolidine-4-carboxylic acid
- ACMC-20emtr
- ACMC-209vwo
- AC1L3FWE
- MLS006011471
- SCHEMBL9342892
- CTK0H7615
- MolPort-004-328-744
- 4-Thiazolidinecarboxylicacid, 3-[[(2S)-5-
- Pidotimodum
- NSC 759841
- DTXCID8026199
- RefChem:174211
- L03AX05
- Pidotomod
- Polimod
- PGT/1A
- Pidotimod [INN]
- Axil
- MFCD00867583
- (R)-3-((S)-5-Oxoprolyl)-4-thiazolidinecarboxylic acid
- Pidotimod (INN)
- NCGC00160516-01
- Pigitil
- Adimod
Look up PIDOTIMOD in the interactive SynDRA portal →